Dual antiplatelet therapy — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Advise adherence and discuss bleeding warning signs
Dual antiplatelet therapy is commonly required after stent insertion for a defined period. Bruising can occur, but the patient should not stop treatment without specialist advice. The pharmacist should reinforce adherence and explain bleeding red flags.
Reference: https://www.pharmacyregulation.org/students-and-trainees/pharmacist-education-and-training/registration-assessment